These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 32989463)

  • 1. Antibody Combinations Targeting the Essential Antigens CyRPA, RH5, and MSP-119 Potently Neutralize Plasmodium falciparum Clinical Isolates From India and Africa.
    Singh H; Mian SY; Pandey AK; Krishna S; Anand G; Reddy KS; Chaturvedi N; Bahl V; Hans N; Shukla MM; Bassat Q; Mayor A; Miura K; Bharti PK; Long C; Singh N; Chauhan VS; Gaur D
    J Infect Dis; 2021 Jun; 223(11):1953-1964. PubMed ID: 32989463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasmodium falciparum Cysteine-Rich Protective Antigen (CyRPA) Elicits Detectable Levels of Invasion-Inhibitory Antibodies during Natural Infection in Humans.
    Mian SY; Somanathan A; Chaddha K; Pandey AK; Singh H; Krishna S; Chaturvedi N; Uchoi S; Shukla MM; Bharti PK; Singh N; Chauhan VS; Gaur D
    Infect Immun; 2022 Jan; 90(1):e0037721. PubMed ID: 34694918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of a potent combination of key Plasmodium falciparum merozoite antigens that elicit strain-transcending parasite-neutralizing antibodies.
    Pandey AK; Reddy KS; Sahar T; Gupta S; Singh H; Reddy EJ; Asad M; Siddiqui FA; Gupta P; Singh B; More KR; Mohmmed A; Chitnis CE; Chauhan VS; Gaur D
    Infect Immun; 2013 Feb; 81(2):441-51. PubMed ID: 23184525
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional Comparison of Blood-Stage
    Illingworth JJ; Alanine DG; Brown R; Marshall JM; Bartlett HE; Silk SE; Labbé GM; Quinkert D; Cho JS; Wendler JP; Pattinson DJ; Barfod L; Douglas AD; Shea MW; Wright KE; de Cassan SC; Higgins MK; Draper SJ
    Front Immunol; 2019; 10():1254. PubMed ID: 31214195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RH5.1-CyRPA-Ripr antigen combination vaccine shows little improvement over RH5.1 in a preclinical setting.
    Healer J; Thompson JK; Mackwell KL; Browne CD; Seager BA; Ngo A; Lowes KN; Silk SE; Pulido D; King LDW; Christen JM; Noe AR; Kotraiah V; Masendycz PJ; Rajagopalan R; Lucas L; Stanford MM; Soisson L; Diggs C; Miller R; Youll S; Wycherley K; Draper SJ; Cowman AF
    Front Cell Infect Microbiol; 2022; 12():1049065. PubMed ID: 36605129
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Strain-Dependent Inhibition of Erythrocyte Invasion by Monoclonal Antibodies Against
    Knudsen AS; Björnsson KH; Bassi MR; Walker MR; Kok A; Cristinoi B; Jensen AR; Barfod L
    Front Immunol; 2021; 12():716305. PubMed ID: 34447381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Passive immunoprotection of Plasmodium falciparum-infected mice designates the CyRPA as candidate malaria vaccine antigen.
    Dreyer AM; Matile H; Papastogiannidis P; Kamber J; Favuzza P; Voss TS; Wittlin S; Pluschke G
    J Immunol; 2012 Jun; 188(12):6225-37. PubMed ID: 22593616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bacterially expressed full-length recombinant Plasmodium falciparum RH5 protein binds erythrocytes and elicits potent strain-transcending parasite-neutralizing antibodies.
    Reddy KS; Pandey AK; Singh H; Sahar T; Emmanuel A; Chitnis CE; Chauhan VS; Gaur D
    Infect Immun; 2014 Jan; 82(1):152-64. PubMed ID: 24126527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Process development and preclinical evaluation of a major
    Somanathan A; Mian SY; Chaddha K; Uchoi S; Bharti PK; Tandon R; Gaur D; Chauhan VS
    Front Immunol; 2022; 13():1005332. PubMed ID: 36211427
    [No Abstract]   [Full Text] [Related]  

  • 10. Identification and Immune Assessment of T Cell Epitopes in Five
    Kotraiah V; Phares TW; Terry FE; Hindocha P; Silk SE; Nielsen CM; Moise L; Tucker KD; Ashfield R; Martin WD; De Groot AS; Draper SJ; Gutierrez GM; Noe AR
    Front Immunol; 2021; 12():690348. PubMed ID: 34305923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bliss' and Loewe's additive and synergistic effects in Plasmodium falciparum growth inhibition by AMA1-RON2L, RH5, RIPR and CyRPA antibody combinations.
    Azasi Y; Gallagher SK; Diouf A; Dabbs RA; Jin J; Mian SY; Narum DL; Long CA; Gaur D; Draper SJ; Fay MP; Miller LH; Miura K
    Sci Rep; 2020 Jul; 10(1):11802. PubMed ID: 32678144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancing blockade of Plasmodium falciparum erythrocyte invasion: assessing combinations of antibodies against PfRH5 and other merozoite antigens.
    Williams AR; Douglas AD; Miura K; Illingworth JJ; Choudhary P; Murungi LM; Furze JM; Diouf A; Miotto O; Crosnier C; Wright GJ; Kwiatkowski DP; Fairhurst RM; Long CA; Draper SJ
    PLoS Pathog; 2012; 8(11):e1002991. PubMed ID: 23144611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of an improved blood-stage malaria vaccine targeting the essential RH5-CyRPA-RIPR invasion complex.
    Williams BG; King LDW; Pulido D; Quinkert D; Lias AM; Silk SE; Ragotte RJ; Davies H; Barrett JR; McHugh K; Rigby CA; Alanine DGW; Barfod L; Shea MW; Cowley LA; Dabbs RA; Pattinson DJ; Douglas AD; Lyth OR; Illingworth JJ; Jin J; Carnrot C; Kotraiah V; Christen JM; Noe AR; MacGill RS; King CR; Birkett AJ; Soisson LA; Skinner K; Miura K; Long CA; Higgins MK; Draper SJ
    Nat Commun; 2024 Jun; 15(1):4857. PubMed ID: 38849365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The RH5-CyRPA-Ripr Complex as a Malaria Vaccine Target.
    Ragotte RJ; Higgins MK; Draper SJ
    Trends Parasitol; 2020 Jun; 36(6):545-559. PubMed ID: 32359873
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of Plasmodium falciparum reticulocyte binding protein homologue 5-interacting protein, PfRipr, as a highly conserved blood-stage malaria vaccine candidate.
    Ntege EH; Arisue N; Ito D; Hasegawa T; Palacpac NMQ; Egwang TG; Horii T; Takashima E; Tsuboi T
    Vaccine; 2016 Nov; 34(46):5612-5622. PubMed ID: 27692771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaccination with conserved regions of erythrocyte-binding antigens induces neutralizing antibodies against multiple strains of Plasmodium falciparum.
    Healer J; Thompson JK; Riglar DT; Wilson DW; Chiu YH; Miura K; Chen L; Hodder AN; Long CA; Hansen DS; Baum J; Cowman AF
    PLoS One; 2013; 8(9):e72504. PubMed ID: 24039774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A malaria vaccine candidate based on an epitope of the Plasmodium falciparum RH5 protein.
    Ord RL; Caldeira JC; Rodriguez M; Noe A; Chackerian B; Peabody DS; Gutierrez G; Lobo CA
    Malar J; 2014 Aug; 13():326. PubMed ID: 25135070
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synergistic malaria vaccine combinations identified by systematic antigen screening.
    Bustamante LY; Powell GT; Lin YC; Macklin MD; Cross N; Kemp A; Cawkill P; Sanderson T; Crosnier C; Muller-Sienerth N; Doumbo OK; Traore B; Crompton PD; Cicuta P; Tran TM; Wright GJ; Rayner JC
    Proc Natl Acad Sci U S A; 2017 Nov; 114(45):12045-12050. PubMed ID: 29078270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generation of Plasmodium falciparum parasite-inhibitory antibodies by immunization with recombinantly-expressed CyRPA.
    Favuzza P; Blaser S; Dreyer AM; Riccio G; Tamborrini M; Thoma R; Matile H; Pluschke G
    Malar J; 2016 Mar; 15():161. PubMed ID: 26979066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neutralising antibodies block the function of Rh5/Ripr/CyRPA complex during invasion of Plasmodium falciparum into human erythrocytes.
    Healer J; Wong W; Thompson JK; He W; Birkinshaw RW; Miura K; Long CA; Soroka V; Søgaard TMM; Jørgensen T; de Jongh WA; Weir C; Svahn E; Czabotar PE; Tham WH; Mueller I; Barlow PN; Cowman AF
    Cell Microbiol; 2019 Jul; 21(7):e13030. PubMed ID: 30965383
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.